{"abstract": "Pharmaceutical companies are on the prowl for deals. | The Allergan bid charts new territory for takeovers. | Preet Bharara\u2019s perfect record is in jeopardy. | Comcast looks to divest subscribers.", "web_url": "https://dealbook.nytimes.com/2014/04/23/morning-agenda-big-pharmas-deal-bonanza/", "snippet": "Pharmaceutical companies are on the prowl for deals. | The Allergan bid charts new territory for takeovers. | Preet Bharara\u2019s perfect record is in jeopardy. | Comcast looks to divest subscribers.", "lead_paragraph": "The pharmaceutical industry is regaining its swagger, Michael J. de la Merced, David Gelles and Rachel Abrams write in DealBook. On Tuesday alone, pharmaceutical companies announced $74 billion worth of potential deals, including an unconventional $45.6 billion bid for Allergan, the maker of Botox, and a flurry of swaps and sales between Novartis of Switzerland and GlaxoSmithKline of Britain. More deals in the cash-rich industry are expected.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Big Pharma\u2019s Deal Bonanza", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2014-04-23T11:46:07+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Sydney Ember", "person": [{"firstname": "Sydney", "middlename": null, "lastname": "Ember", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/02a31d94-eb4e-5a60-b361-9be61b7fa04d", "word_count": 1881, "uri": "nyt://article/02a31d94-eb4e-5a60-b361-9be61b7fa04d"}